Director, Global Medical Affairs Strategy - Solid Tumors

At Genmab, we are dedicated to building extraordinary futures together by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals' unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees. Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.

Director, Global Medical Affairs Strategy - Solid Tumors

The Role

The Genmab pipeline comprises robust and diverse antibody products in immuno‑oncology and beyond. Reporting to the Global Medical Affairs Strategy Lead (MASL), the Director will be responsible for the development and execution of the Global Medical Affairs strategic and tactical plans for the asset(s) for the primary indication as well as new indications to expand into as part of the asset life cycle management. The Director should have a strong background and experience in the field of solid tumors, with proven ability to translate and align commercial and scientific goals and objectives into actions. The Director will work as an integral part of the Medical Affairs Strategy Team in close alignment with the Global Medical Affairs Strategy Lead and the cross‑functional medical affairs cross‑functional partners, providing input and strategic direction for the program. The Director will also support data generation and life cycle management initiatives as well as establish and maintain the relationships with the global thought leaders in support of the programs.

Job Responsibilities

• Lead annual medical planning for asset(s); Work closely with extended medical affairs functions (global and regional markets) to inform and implement overall medical strategy for designated products and / or therapeutic areas
• Lead and execute on engagement strategy with thought leaders, patient advocacy groups, professional societies and institutions
• Lead the planning and execution of Early Access Program, and investigator initiated trials program, within appropriate standards for compliance, quality, timeliness, and budget - in alignment with MASL
• Contribute and execute on the life cycle management of the asset(s)
• Drive collaboration with cross‑functional teams (e.g. commercial, field / regional, medical information / communication, HEOR) to provide support, medical review, and medical expertise advice as required
• Collaborate with medical and clinical operations departments to coordinate the planning, execution, and management of clinical trial activities across medical affairs functions
• Contribute to effective publication planning to ensure consistent and meaningful scientific communication
• Contribute to the development of internal guidance and process / resource documents
• Contribute to development and review of regulatory documents for regulatory submissions
• Serve as medical reviewer and expert on promotional and medical review committees
• Inform development of strategies to demonstrate the value of disease / products with focus on payer and clinical decision‑maker outcomes
• Lead the strategy team congress activity planning in collaboration with cross‑functional stakeholders, and compiling of congress reports including key competitive intelligence
• Lead and collaborate on cross‑functional launch activities globally

Requirements

Salary

For US based candidates, the proposed salary band for this position is $203,840.00 $305,760.00. The actual salary offer will carefully consider a wide range of factors, including your skills, qualifications, experience, and location. Also, certain positions are eligible for additional forms of compensation, such as discretionary bonuses and long‑term incentives.

Benefits

About You

Locations

Genmab maximizes the efficiency of an agile working environment, when possible, for the betterment of employee work‑life balance. Our offices are crafted as open, community‑based spaces that work to connect employees while being immersed in our powerful laboratories. Whether you're in one of our office spaces or working remotely, we thrive on connecting with each other to innovate.

About Genmab

Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard‑working, innovative and collaborative team has invented next‑generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T‑cell engagers, antibody‑drug conjugates, next‑generation immune checkpoint modulators and effector function‑enhanced antibodies. By 2030, Genmab's vision is to transform the lives of people with cancer and other serious diseases with Knock‑Your‑Socks‑Off (KYSO®) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X.

Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com).

Note that if you are applying for a position in the Netherlands, Genmab's policy for all permanently budgeted hires in NL is initially to offer a fixed‑term employment contract for a year; if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the fixed‑term employment contract.

#J-18808-Ljbffr